CURRENT REPORT

Company

Akari Therapeutics Plc

Filed

September 15, 2015

Period of Report

September 9, 2015

Accession Number

0001144204-15-055045

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →